Ramsay Health Care
RHC.ASXHealth Care
Ramsay Health Care Limited is a global hospital group owning and operating a comprehensive range of healthcare facilities across Australia, France and the United Kingdom.
Market Data
$36.185
-0.0%$8.6B
31.4x
$1.183
2.22%
-0.0%
Latest Earnings
2026 Half Year Results Announcement
26 February 2026
Ramsay Health Care reported strong half-year results with underlying NPAT growing 8.1% to $171.7M, driven by improving performance in Australia where underlying EBIT increased 7.1%. The company raised its fully franked interim dividend to 42.5 cents (up 6.3%) and is making good progress on strategic transformation priorities while reducing full-year capex guidance. Key points: Underlying NPAT growth of 8.1% driven by improving Australian business performance; Australian EBIT margins ex-Joondalup improved 40 basis points with strong admissions growth; Fully franked interim dividend increased 6.3% to 42.5 cents with 60% payout ratio
Recent Announcements
Becoming a substantial holder
Vanguard Group (The Vanguard Group, Inc. became a substantial holder (5.001%).
2026 Half Year Results Presentation
Ramsay Health Care released its 1H FY26 results showing underlying NPAT growth of 8.1% and EPS growth of 8.6%, with a fully franked dividend of 42.5 cents per share (up 6.3%). The company plans to separate Ramsay Santé via an in-specie distribution to shareholders by end of 2026, while continuing transformation efforts in Australia and managing turnarounds in the UK and Europe.
2026 Half Year Results Announcement
Ramsay Health Care reported strong half-year results with underlying NPAT growing 8.1% to $171.7M, driven by improving performance in Australia where underlying EBIT increased 7.1%. The company raised its fully franked interim dividend to 42.5 cents (up 6.3%) and is making good progress on strategic transformation priorities while reducing full-year capex guidance. Key points: Underlying NPAT growth of 8.1% driven by improving Australian business performance; Australian EBIT margins ex-Joondalup improved 40 basis points with strong admissions growth; Fully franked interim dividend increased 6.3% to 42.5 cents with 60% payout ratio
Earnings Release - 26 February 2026
Upcoming earnings release expected 26 February 2026 (from Yahoo Finance (confirmed))
Ramsay Sante 1QFY26 Earnings Update
Ramsay Santé delivered Q1 FY26 revenue of €1,207m (+2.6% reported, +1.9% organic) with EBITDA growth of 6.5% to €112m despite a €7m headwind from the end of France's revenue guarantee. Strong cost control and productivity gains offset inflation pressures, with EBITDA margin expanding 0.3 percentage points and pre-IFRS16 net leverage improving to 5.2x from 5.3x year-over-year. Key points: EBITDA grew 6.5% to €112m despite loss of €7m French revenue guarantee, demonstrating resilient operational performance; Organic revenue growth of 1.9% supported by volume expansion in acute hospital admissions across France and Sweden, plus price indexation; EBITDA margin improved 0.3 percentage points through disciplined cost management, productivity gains, and optimized procurement despite inflation
Financial Results for the Year Ended 30 June 2025
Ramsay Health Care reported FY25 revenue of A$17.8B (+6.8% YoY) with solid performance in Australian private hospitals and UK operations, though underlying net profit after tax increased modestly to A$305.3M (+1.7%). The result was significantly impacted by a A$291M non-cash impairment of the UK region (primarily Elysium underperformance), and the company is executing a multi-year transformation with disciplined capital deployment and improved private health insurance indexation, while evaluating strategic options for its Ramsay Santé stake. Key points: Revenue growth of 6.8% to A$17.8B driven by solid Australian private hospital portfolio performance with 3.2% increase in surgical admissions (ex-Peel) and improved indexation from all major payors; UK hospitals business delivered strong performance with 7.6% growth in NHS admissions and higher case acuity, with underlying EBIT up 21.4% YoY to A$147.3M; Underlying NPAT from continuing operations grew 1.7% YoY to A$305.3M, with underlying EPS increasing 1.2% to 125.3 cents, supported by Funding Group NPAT growth of 6.5% (constant currency)
Preliminary Final Report
Ramsay Health Care reported FY25 revenue of $17.8B (+6.8% YoY) with underlying NPAT of $305.3M (+1.7%), driven by improved UK acute hospital performance and solid Australian private hospital activity, partially offset by weaker Elysium and Ramsay Santé results. Reported NPAT of $24.0M reflects a $305M UK impairment and the prior year's $618M gain from the Sime Darby divestment; the company maintained a full-year dividend of 80 cents per share (63.7% payout ratio) with leverage at 2.18x within target range. Key points: Underlying NPAT increased 1.7% to $305.3M reflecting resilience in core operations despite macroeconomic headwinds; Revenue growth of 6.8% across all regions driven by activity growth and payor indexation, with UK segment revenue up 12.7%; Funding Group leverage of 2.18x maintained within target range of <2.5x, demonstrating disciplined capital management
Get real-time alerts for RHC
Receive AI-powered earnings summaries and instant notifications when Ramsay Health Care releases results.
Register Free